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 Bovine viral diarrhea (BVD) is an economically important disease of cattle. 
Calves persistently infected (PI) with the bovine viral diarrhea virus (BVDV) are a 
powerful agent for spread of the virus. A total of 24,423 southeast origin beef cattle 
comingled at three Warren County, Kentucky locations were tested from November 2007 
to June 2010 for PI BVDV. A total of 97 head tested positive for PI BVDV, giving an 
average overall prevalence of 0.397%. 
 Calves tested were subdivided into categories for additional calculations of 
dependence.  A total of 8,910 were categorized by weight range upon testing (300-399 
lbs, 400-499 lbs, 500-599 lbs, and 600-699 lbs). Prevalence does show a dependence on 
weight, with a higher prevalence found in lower weight classes, especially 300-399 lb 
calves (P<0.001). A total of 24,423 were categorized by season at time of testing (Fall, 
Winter, Spring, Summer). Prevalence does not show a dependence on season (P>0.05). 
 Although eradication programs are not likely to be organized in the United States, 
several control programs have been developed. These findings can be used as additional 
support for PI testing of calves, especially those in lighter weight classes, as part of a 
BVD control program. 
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Chapter One 
Introduction 
 Bovine Viral Diarrhea (BVD) is a major disease that negatively affects beef and 
dairy cattle worldwide. The Bovine Viral Diarrhea Virus (BVDV) is a single-stranded 
RNA virus that is not usually fatal, but has a negative impact because it suppresses the 
immune system of infected cattle and makes them more susceptible to other diseases 
(Bolin, Grooms, 2004). Cattle affected by BVDV can be of any age; older cattle may 
have reproductive failure, abortions, and decreased performance and production, and 
calves may experience lower weaning weights and rates of gain (van Campen, 2010). 
BVDV can affect every aspect of a beef operation, from seed-stock, cow-calf, stocker 
operations, to feedlots (Ridpath, 2009). Because of these conditions, producers 
experience an overall economic loss when cattle are affected by BVDV. 
  A major source of BVDV is cattle that are persistently infected (PI). PI calves 
shed extremely high numbers of virus particles for life, making them a powerful agent for 
its spread (Fulton, 2005). A calf becomes persistently infected when it is exposed as a 
fetus to the BVD virus between days 42 and 125 of gestation (Fulton et al., 2009). For a 
PI calf to become exposed, the dam must be either persistently infected herself, or she 
must have been exposed to the virus at this period of gestation (Fulton et al., 2009). 
 BVD is not a new disease in cattle, as it was first identified in the 1940’s 
(Ridpath, 2010). However, because of the development and availability of new tools and 
diagnostic tests to identify PI animals, there has been an increase of interest in this area 
and in the possibility of control or eradication of BVD. Diagnostic tests for detection of 
PI animals include antigen-based testing methods such as antigen-capture ELISA 
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(Ridpath, 2009). Testing and removing PI animals helps break the BVD cycle and 
decreases the spread of the virus. Controlling the disease requires identifying and 
eliminating PI cattle from the herd, maintaining good records, developing a plan to keep 
PI cattle from entering the herd, and keeping a PI calf from being created in the herd by 
developing and following a sound vaccination program (Brock et al., 1998). 
 This study was developed to gain a better understanding of the prevalence of PI 
beef cattle of southeast US origin comingled in Warren County, KY. It was also 
developed to determine whether there is a significant relationship or dependence between 
prevalence and weight classes, or prevalence and season. 
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Chapter Two 
Review of Literature 
BACKGROUND- HISTORY AND CLASSIFICATION OF BVDV 
 The first recorded observation of bovine viral diarrhea (BVD) dates to 1946, in a 
New York dairy (Olafson et al., 1946). The new disease was found to cause leukopenia, 
pyrexia, depression, diarrhea, anorexia, gastrointestinal erosions, and hemorrhages in 
cattle (Ridpath, 2010). In 1957, the causative viral agent was isolated and termed the 
bovine viral diarrhea virus (BVDV) (Lee et al., 1957). 
 Along with classical swine fever virus (CSFV) found in hogs and border disease 
virus (BDV) found in sheep, BVDV is currently classified as a member of the genus 
Pestivirus within the family Flaviviridae (Fan, Wang, 2009). BVDV is a single-stranded, 
positive-sense RNA virus, and is classified based on genotype and biotype (Fray et al., 
2000).  
 The two genotypes, BVDV1 and BVDV2, are based on phylogenetic analysis of 
differences in the viral genome, and also on antigenic differences; antigenic differences 
are shown by differences in cross-neutralization and monoclonal antibody binding 
patterns (Bachofen et al., 2010; Fulton et al., 2006; Ridpath, 2010). The BVDV1 and 
BVDV2 genotypes can be further divided into subgenotypes: 12 subgenotype groupings 
within the BVDV1 species (BVDV1a, BVDV1b, etc) and two subgenotype groupings 
within the BVDV2 species (BVDV2a and BVDV2b) (Ridpath, 2010). Genotypes of the 
BVDV are about 60% similar to each other at their base sequence, and subgenotypes are 
about 80% to 85% similar to each other (Bolin, Grooms, 2004). Subgenotypes BVDV1a, 
BVDV1b, BVDV2a, and BVDV2b are the most common that are found in North 
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America (Fulton et al., 2006). Predominance of these different BVDV subgenotypes 
varies according to different geographic locations (Ridpath, 2010). This is accounted for 
most likely by routes of movement of cattle, vaccine usage, and geographic isolation of 
cattle populations (Bolin, Grooms, 2004). 
 Independent of genotype, BVDV strains are also classified by biotype based on 
their effect on cultured cells. The non-cytopathic (NCP) biotype replicates in cultured 
cells without inducing cell death, while the cytopathic (CP) biotype induces cytoplasmic 
vacuolation and cell death of cultured cells within a few days of infection (Fray et al., 
2000; Ridpath, 2010). In the field, the NCP biotype is most common, while the CP 
viruses are more rare (Fray et al., 2000; Ridpath, 2010). CP viruses are usually coisolated 
with a NCP virus from tissues of cattle with signs of mucosal disease (Bolin et al., 2009; 
Ridpath, 2010). CP viruses are the result of either homologous or heterologous 
recombination of the parent NCP viral RNA; reversion of the CP virus back to the NCP 
biotype may also occur (Bolin, Grooms, 2004; Bachofen et al., 2010).  
 Like other RNA viruses, the BVDV is able to mutate rapidly (Bolin, Grooms, 
2004; Bolin et al., 2009).  
 
EFFECTS OF BVDV 
 The BVDV can be spread in a variety of ways, including transmission from 
acutely infected cattle, by inanimate objects that may carry the virus, bovine sera, rectal 
examination, fluids used for embryo transfer, infected semen, and contaminated vaccines 
(Fray et al., 2000). 
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 Following infection with BVDV, depending on the agent, host, and environment, 
a wide range of outcomes can occur that vary in severity. Factors include “whether the 
host is immunotolerant or immunocompetent to BVDV, immune status (passive from 
colostral antibodies or active from exposure or vaccination), pregnancy status in females, 
gestational age of the fetus at the time of infection, level of environmental stress at the 
time of infection, and concurrent infection with other pathogens” (Bolin, Grooms, 2004).  
 The majority of BVDV isolates are of low virulence and induce subclinical to 
very mild disease; subclinical infections can result in mild fever, leukopenia, and in the 
majority of unvaccinated cattle, development of serum-neutralizing antibodies (Bolin, 
Grooms, 2004). It is estimated that 70% to 90% of BVDV infections are subclinical 
(Ames, 1986).  
 However, BVDV infections may also lead to clinical disease; in cattle, the BVD 
virus causes diseases that are termed BVD, mucosal disease, chronic BVD, virulent acute 
BVD, and hemorrhagic syndrome (Bolin et al., 2009). BVD most commonly results in 
lethargy, anorexia, fever, diarrhea, and decreased milk production in lactating cows 
(Bolin, Grooms, 2004). Severe BVD causes high morbidity; this peracute infection is 
characterized by fever, pneumonia, and sudden death in all age groups of cattle (Carman 
et al., 1998). Acute BVD infections can lead to hemorrhagic syndrome, which can cause 
severe thrombocytopenia, bloody diarrhea, epistaxis, hemorrhages on mucosal surfaces, 
hyphema, bleeding from injection sites, pyrexia, leukopenia, and death (Corapi et al., 
1990). Except in the cases of some hypervirulent type 2 BVDV strains that cause the 
lethal severe acute BVD, most of the BVDV biotypes cause acute infection, and the hosts 
can effectively clear the virus by their own immunity (Fan, Wang, 2009). 
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 Pestiviruses encode two unique proteins that have an affinity for cells involved in 
the immune system: a nonstructural protein (Npro) that suppresses the host’s immune 
system by preventing production of type I interferon, and an envelope glycoprotein (Erns) 
that prevents the induction of beta interferon by binding to and degrading double-stranded 
RNA (Ridpath, 2010). As a member of the Pestivirus genus, BVDV can cause infection 
resulting in immunosuppression of the host, increasing its susceptibility to other 
pathogens and enhancing the pathogenicity of any coinfecting pathogen (Bolin, Grooms, 
2004). BVDV infections have been associated with Mannheimia haemolytica, bovine 
herpesvirus-1, bovine respiratory syncytial virus, salmonellosis, Escherichia coli, bovine 
popular stomatitis, rotavirus, and coronavirus infections (Bolin, Grooms, 2004). BVDV 
has been reported as the most common virus isolated from outbreaks of bovine 
respiratory disease (BRD) in the United States (Bolin, Grooms, 2004). It usually does not 
cause disease alone, but can work with M haemolytica (Potgieter et al., 1984), bovine 
herpesvirus (Potgieter et al., 1984), or the bovine respiratory syncytial virus (Broderson, 
Kelling, 1998) to cause BRD, especially in a stressful environment. 
 BVDV also has a major effect on reproduction in cattle. In infected bulls, semen 
quality may decrease, and infected cows may have decreased conception rates, increased 
early embryonic deaths, abortions, and still-births, and calves may have congenital 
defects (Bolin, Grooms, 2004; Fray et al., 2000; Bolin et al., 2009). Conception rates may 
fall by up to 44% (Fray et al., 2000). If the dam becomes exposed to the BVDV during 
mid-gestation, a higher rate of congenital abnormalities occur, such as alopecia, 
pulmonary hypoplasia, retarded growth, thymic aplasia, ataxia, cerebellar hypoplasia, 
CNS defects, and ocular lesions (Fray et al., 2000). If the dam becomes exposed to the 
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BVDV later in gestation, congenital abnormalities still occur but are less common, and 
there is still a risk of abortion; however, most calves infected late in gestation are born 
clinically normal and have high levels of pre-colostral antibodies (Fray et al., 2000). 
 In regards to spread of the disease, the greatest effect of BVDV occurs when the 
dam is exposed to the virus early in gestation, between days 42 and 125; through 
transplacental infection, the fetus can become immunotolerant to and is persistently 
infected (PI) with the BVDV (Bolin, Grooms, 2004; Fulton et al., 2009).  
 Type 1 BVDV more often results in PI, congenital defects, and weak calves, and 
Type 2 BVDV more often results in aborted fetuses (Evermann, Ridpath, 2002). 
 Costs associated with BVD can vary according to the type of operation. Ridpath 
(2002) states that BVD can result in costs of $35.00 to $65.00 per calving on a US dairy. 
Costs on a US beef cow-calf operation can range from $15.33 to $20.16 per cow (Larson 
et al., 2002), and are $41.17 per head on a US beef feedlot (Hessman, 2006). 
 
PI CALVES 
 Only the NCP biotype can cause persistent infection (PI) of the fetus (Bachofen et 
al., 2010; Bolin et al., 2009).  As a result of fetal infection before the onset of 
immunologic competence, PI calves are immunotolerant to the infecting viral strain, 
differing from other persistent viral infections in humans and animals (Bachofen et al., 
2010; Bolin et al., 2009; Peterhans et al., 2006).  Immunotolerance in the PI calf is 
specific to only the particular infecting BVDV strain (Bolin, Grooms, 2004). The PI calf 
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remains infected for life and sheds large quantities of the virus (Bachofen et al., 2010). A 
PI calf sheds one million to 10 million virus particles every day of its life, in comparsion 
to a BVD animal, which sheds 1,000 to 10,000 virus particles a day for a period of only 
six to 10 days (IDEXX Laboratories Inc., 2008). Because of the efficiency by which PI 
animals can spread BVDV, PI animals should be accounted for and included in any 
control or eradication program. 
 Calves born PI may either be stunted and weak, or normal in size and in 
appearance; although some PI calves appear clinically normal, they frequently are poor 
doers and have a short life span and leave the herd prematurely (Fray et al., 2000; Bolin 
et al., 2009). PI animals often have chronic intestinal or pulmonary symptoms, and may 
also have dermatological, neurological, or haematological disorders (Bachofen et al., 
2010). Persistent infection not only affects the fetus, but it can also affect the immune 
response of the dam by leading to down-regulation of important signaling pathways in 
her blood (Drovers, 2009). 
 If a PI calf is exposed to a CP BVDV biotype, mucosal disease (MD) may occur 
(Bolin, Grooms, 2004). Both NCP and CP BVDV biotypes will be isolated in MD, which 
helps in diagnosis of the disease (Bachofen et al., 2010). Not every combination of NCP 
and CP virus will result in MD; the CP biotype must be homologous to the persisting 
NCP biotype (Bolin, Grooms, 2004). MD can occur in both BVDV Type 1 and Type 2 
genotypes (Bolin, Grooms, 2004). Modified-live BVDV vaccines and super-infection 
with the CP BVDV can lead to MD (Bolin, Grooms, 2004). The disease is usually lethal, 
and causes mucosal lesions, destruction of the lymphoid tissue in the gastrointestinal 
tract, and untreatable diarrhea (Bachofen et al., 2010). 
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 PI calves have an effect on every sector of the beef cattle industry. After exposure 
of the susceptible nonvaccinated penmates to a PI calf in a feedlot situation, 70% to 
100% become infected with BVDV (Fulton et al., 2005; Fulton et al., 2006). According 
to Loneragan and colleagues (2005), 15.9% of initial cases of BRD are attributable to 
exposure to PI calves. According to van Campen (2010), feedlots are the endpoint for the 
BVD virus in terms of transmission, but the economic effect is easily seen on feeder 
calves, which accounts for strong interest in control of BVDV in this segment of the 
industry. 
 In cow-calf operations, synchronous, seasonal breeding is common, and, 
depending on the time of exposure, contact with a single PI calf through shared pasture 
can have significant detrimental effects on the pregnant cows: there may be an increase in 
infertility, abortions, stillbirths, and birth of calves that are weak or stunted (van Campen, 
2010). If the dam is exposed to the BVDV and a PI calf is created, but it is either not born 
or dies before it is able to infect the breeding herd, there is no sustained effect of BVDV 
infection on the herd (van Campen, 2010). However, if the PI calf survives into the 
breeding season, the herd may enter an endemic state of infection (van Campen, 2010).  
After PI exposure and BVDV infection of the breeding herd, up to 50% of the calf crop 
may be lost (van Campen, 2010). Of those exposed calves that survive, many will 
experience diarrhea and pneumonia after maternal antibodies wane, and will also have 
lower weaning weights and lower rates of gain (van Campen, 2010). 
 In addition to shared pastures, high risk practices in the beef industry also include 
heifer development feedlots and the purchase of untested cattle and pregnant heifers (van 
Campen, 2010). Purchased cattle also often pass through multiple sales facilities, or may 
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be purchased from multiple sources and then comingled at a high animal density (van 
Campen, 2010).   
  
DETECTION OF PI CALVES/ DIAGNOSTIC TOOLS 
 Since persistently infected animals are a continuous source of the BVDV, the 
identification and removal of PI animals is an important part of any prevention or control 
program (Brock et al., 1998). After the wane of maternal antibodies, PI calves usually 
have detectable amounts of the NCP virus in their serum, with concentrations of 104- 106 
CCID50/ mL of serum (Brock et al., 1998).  A variety of diagnostic tools are available 
that may target the viral antigens (ex: immunoperoxidase microtiter assay, antigen-
capture [Ag]ELISA, immunochemistry [IHC], fluorescent antibody), genomic material 
(ex: traditional and real-time reverse transcription PCR, in situ hybridization), or BVDV 
specific antibodies (ex: virus neutralization, antibody ELISA) (Bolin, Grooms, 2004; 
Brock et al., 1998). 
 In antigen detection assays, either monoclonal or polyclonal antibodies are used to 
detect BVDV antigens (Bolin, Grooms, 2004). Monoclonal antibodies are specific for a 
single epitope, and binding of the antibody may not occur if there is any epitope variation 
between viruses (Bolin, Grooms, 2004). However, polyclonal antibodies react with 
multiple epitopes, and these are often conserved among viruses (Bolin, Grooms, 2004). 
Therefore, “most antigen detection assays use polyclonal antibodies or a pool of 
monoclonal antibodies to provide the broadest reactivity and capability of detecting a 
diverse population of BVDV isolates” (Bolin, Grooms, 2004). 
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  Antigen detection assays such as IHC and AgELISA are very accurate and cost 
effective at detecting both BVDV-infected calves and PI calves (Cornish et al., 2005). 
Although tested individually, large numbers of animals can be tested without difficulty 
because samples can be easily collected when calves are processed or handled, either by 
obtaining ear notches or blood samples (Cornish et al., 2005). According to Cornish and 
colleagues (2005), the IHC test provides results in 5 days, while the more time-efficient 
and less labor-involved AgELISA test can provide results in as soon as one day. Since 
both acute and persistent infection result in a positive diagnosis, a positive animal should 
be tested again 30 days after the initial test to make a final diagnosis (Cornish et al., 
2005). Testing is also cost-efficient, as the AgELISA test offered through IDEXX 
(HerdChek BVD Antigen Test Kit) costs less than $5 per head (IDEXX, 2008).  The 
IDEXX HerdChek BVD Antigen Test Kit is a USDA-licensed test based on the Erns 
(gp48) antigen, and it detects both type 1 and type 2 BVDV, with 100% sensitivity and 
100% specificity on skin samples (IDEXX, 2008). 
 Edmonson and colleagues (2007) state that isolation of the viral antigen from 
serum and then identification of the viral isolate by immunofluorescence or 
immunoperoxidase monolayer assay is one of the most reliable diagnostic techniques. 
  Polymerase chain reaction (PCR) detects and amplifies the viral genomic 
sequence (Bolin, Grooms, 2004). Pooling of samples is common when using PCR as a 
diagnostic tool; when determining the size of the pool, the pooling protocol should use 
the fewest number of tests required to identify all animals PI with BVDV in a herd 
(Edmonson et al., 2007). According to Edmonson and colleagues (2007), there is an 
inverse ratio between prevalence and pool size: the optimum number of samples in an 
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initial pool would be 20 to 30 for a PI prevalence of 0.5% to 1.0%, and as prevalence 
increases the least-cost initial pool size decreases. 
   
CONTROL OF DISEASE  
 Testing is the only way to correctly identify PI calves, as they are not always 
identifiable based on sight. Therefore, testing and removal of PI animals should be an 
important part of any control program (Brock et al., 1998).  
 Vaccination is also an important facet of control; an estimated 80% of cattle in the 
US are vaccinated with either inactivated or modified live viral vaccines (MLV) 
containing BVDV (USDA, 1995; USDA, 2007). Control programs include the use of 
inactivated and MLV BVDV vaccines to prevent fetal infections, reproductive losses, and 
acute infections (van Campen, 2010). Prior to 2004, vaccines contained cytopathic Type 
1a BVDV (either Singer or NADL), but after the recognition that Type 2 BVDV can lead 
to severe disease and fetal losses, a cytopathic Type 2 BVDV was also included in many 
vaccines (van Campen, 2010). MLV vaccines have been shown to offer superior 
protection, but there are still some concerns about their safety and effects on health (van 
Campen, 2010).  
 Vaccine failure is most common and fetal protection is most limited when the 
challenge virus is a different genotype than the vaccine virus (Bolin et al., 2009). Several 
studies do show vaccination with Type 1 BVDV does induce some clinical cross 
protection against Type 2 challenge (Bolin, Grooms, 2004). However, Drovers (2009) 
cites a study in which Fulton and colleagues found that the majority of viral isolates from 
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PI cattle were of the BVDV Type 1b subtype, while current USDA approved vaccines 
primarily contain BVDV Type 1a and Type 2a, suggesting that complete protection is not 
offered. Vaccination of feeder calves is beneficial, but to gain complete protection, 
ideally, vaccination should also include the breeding herd for control of reproductive 
failure and prevention of fetal infection, and the subsequent birth of PI calves (Bolin, 
Grooms, 2004; Fernandez et al., 2009). Regarding fetal protection, complete cross 
protection may not be provided from current vaccines; according to Bolin and Grooms 
(2004), experimental fetal protection trials have ranged in efficacy from 25% to 100%, 
depending on the type of challenge virus and vaccine virus.   
 Vaccine strategies are varied, and many focus on vaccination at critical periods of 
production (Bolin et al., 2009). However, vaccines are often not given consistently or 
appropriately (Carruthers, Petrie, 1996). According to Bolin and colleagues (2009), three 
assumptions are often made that may lead to failure of a vaccine program; these 
assumptions are that the vaccine was handled properly before vaccination, that the herd 
was appropriately vaccinated, and that all cattle within the herd have an equal immune 
response to the vaccine. Producers that do not take these assumptions into account may 
experience apparent vaccine failure (van Campen, 2010). 
 Any control program that includes proper vaccination and testing should also 
include strict biosecurity measures to sustain a BVDV-free population (Fray et al., 2000). 
The number of BVD control programs has increased since 2003, when the Academy of 
Veterinary Consultants published a position statement (http://www.avc-
beef.org/links/BVDLinks.asp) on the control and possible eradication of BVD in the 
United States (van Campen, 2010). According to van Campen (2010), as of 2010 there 
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are beef control programs in Alabama, Colorado, Georgia, Mississippi, Montana, Oregon, 
and Washington, and a dairy control program in New York. The current control programs 
are all voluntary, associated with a university, and work along with other beef and dairy 
quality assurance programs (van Campen, 2010). The control programs include 
“education about BVDV transmission and diseases, required testing procedures, 
documentation of biosecurity practices to prevent re-introduction of BVDV, and verified 
use of a vaccination schedule” (van Campen, 2010). 
 Although mandatory BVD control programs exist in several European countries, 
there are not currently any mandatory programs in place in the United States (van 
Campen, 2010). Several obstacles exist, including the need for a control program to be 
government-regulated, and the belief that there is a lack of clear danger, based on low 
herd prevalences (van Campen, 2010). 
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Chapter Three 
Materials and Methods 
 As an initial step, in the fall of 2009, a visit was made with Sandy Grant at the 
Gold Standard diagnostic lab in Bowling Green, KY, to discuss the Bovine Viral 
Diarrhea Virus and the methods used at the lab for testing persistently infected (PI) cattle. 
Several additional visits were conducted to gain experience in running the AgELISA 
diagnostic test (IDEXX HerdChek BVD Antigen Test Kit) used at this location. Also in 
the fall of 2009, a visit was made to Farm A in Warren County, KY, to gain knowledge 
on obtaining ear-notch and serum samples. PI test results (positive or negative) from 
November 2007 to June 2010 were obtained from the herd veterinarian in Bowling 
Green, KY on beef cattle from Farms A and B. Additional test results and weight range 
of those tested were obtained from Farm C. Data for this study were obtained first hand 
by collecting ear-notch and serum samples, then testing them at Gold Standard diagnostic 
laboratory, and also by obtaining previous and current testing records. Records were 
obtained from Farms A and B herd veterinarian for positive or negative test results on 
cattle from November 2007 to June 2010. Records were obtained from Farm C diagnostic 
lab for results from April 2009 to June 2010. 
 Study animals from each beef operation were of Kentucky, Tennessee, or 
Alabama origin, and ranged from 300 to 600 pounds when processed upon arrival. All the 
calves were assumed to be naïve to vaccination when initially processed. All calves that 
were purchased and processed were tested to determine if they were persistently infected 
with the bovine viral diarrhea virus. 
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 Ear notching was the most common method by which samples for testing were 
obtained. Calves were restrained in a chute and, using V-type ear-notchers, a full notch 
was taken from the top portion of the ear to reduce the amount of hair. The notch was 
placed in a sample vial containing enough phosphate buffered solution (PBS) for the 
sample to be submerged. The sample vial was labeled, and the corresponding animal ID’s 
and sample vial ID’s were recorded. To reduce spread of disease and to decrease chances 
of inaccurate test results, the ear notchers were then rinsed in a clean water vessel to 
remove any hair, then disinfected in a vessel containing diluted chlorhexidine (1 ounce 
chlorhexidine: 1 gallon water), and then in another clean water vessel to rinse remaining 
disinfectant. After all the ear-notch samples were gathered, the sample vials were 
immediately boxed in trays along with cold packs and lab submission forms and sent to 
the appropriate lab for diagnostic testing. Samples not sent out were refrigerated and then 
sent as soon as possible. 
 Blood collection was a less common method by which samples for testing were 
obtained. While the calf was restrained in the chute, a 3 cc blood sample from either the 
neck or the tail was collected in a marble top tube. The sample was centrifuged and the 
serum was sent to the appropriate diagnostic lab for testing. 
 Samples from Farms A and B were tested for PI BVDV with an antigen capture 
ELISA test at the Elizabethtown, KY, Central States Testing diagnostic lab location. 
 Samples from Farm C were tested for PI BVDV with an antigen capture ELISA 
test at the Bowling Green, KY, Gold Standard diagnostic lab location.  
Results from the diagnostic labs were available within as few as 5 hours. 
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 Data from Farms A, B, and C were compiled in a Microsoft Excel spreadsheet 
and organized by specific location, date, total number tested, and number testing positive 
and negative.  
 Data from Farm C were also grouped by weight range at time of testing. 
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Chapter Four 
Results 
 All data obtained from beef cattle testing positive or negative for persistent 
infection with BVDV from November 2007 to June 2010 are listed by date and location 
in Table 1. A total of 97 out of 24,423 tested positive as PI BVD, giving an overall 
prevalence of 0.397%. 
 
Table 1. Beef cattle testing positive for PI BVD by location (Nov 2007 to June 2010). 
Location Total number 
tested 
Total number 
positive 
Prevalence (%) 
FARM A 9271 39 0.421 
FARM B 6242 24 0.384 
FARM C 8910 34 0.382 
TOTAL 24,423 97 0.397 
 
 
 Data obtained from Farm C cattle testing positive or negative for persistent 
infection with BVDV from April 2009 to June 2010 are listed by weight range in Table 2. 
Calves were grouped by weight range regardless of season. 
 
Table 2. Farm C- beef cattle testing positive for PI BVD by weight range (April 2009 to June 2010). 
Weight range (lbs) Total number 
tested 
Total number 
positive 
Prevalence (%) 
300-399 1491 15 1.006 
400-499 3283 9 0.274 
500-599 3694 9 0.244 
600-699 442 1 0.226 
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 Data obtained from beef cattle at all three farm locations testing positive for PI 
BVD from November 2007 to June 2010 are listed by season in Table 3. 
 
Table 3. Beef cattle testing positive for PI BVD by season (Nov 2007 to June 2010). 
Season Total number 
tested 
Total number 
positive 
Prevalence (%) 
Fall 
(Sept 22- Dec 21) 
7419 28 0.377 
Winter 
(Dec 22- March 21) 
4459 15 0.336 
Spring 
(March 22- June 21) 
8189 36 0.440 
Summer 
(June 22- Sept 21) 
4356 18 0.413 
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 A contingency chi-square was used to determine if prevalence of PI BVDV has 
dependence on weight (Table 4). The calculated χ2 value of 18.362 is greater than critical 
χ2 values at the 0.05, 0.01, and 0.001 levels: 7.815, 11.345, and 16.266, respectively. 
Therefore, the null hypothesis is rejected at the 0.001 level; frequency (prevalence) does 
depend on category (weight), and the major contributor to the outcome is in the first 
category (300-399 lbs). 
 
Table 4. Contingency Chi-Square; Farm C beef cattle testing positive for PI BVD by weight. 
Weight 
range (lbs) 
 Positive Negative Total 
300-399 O 15 1476 1491 
 E 5.69 1485.31  
 (O-E)2/ E 15.23 0.06  
400-499 O 9 3274 3283 
 E 12.53 3270.5  
 (O-E)2/ E 0.94 0.004  
500-599 O 9 3685 3694 
 E 14.10 3679.90  
 (O-E)2/ E 1.84 0.007  
600-699 O 1 441 442 
 E 1.69 440.31  
 (O-E)2/ E 0.28 0.001  
Total  34 8876 8910 
 
χ2 = ∑ (O-E)2/ E 
calculated χ2 = 18.362; df = 3 
critical χ2 (0.05, 3) = 7.815 
critical χ2 (0.01, 3) = 11.345 
critical χ2 (0.001, 3) = 16.266 
In the contingency chi-square, O= observed frequency and E= expected frequency in 
each classification. E is calculated by multiplying the respective row total by the 
respective column total and dividing by the overall total. The 15.23 component of the χ2 
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for the 300-399 lbs positive classification= 34 x 1491/ 8910= 5.69; (15-5.69)2/ 5.69= 
15.23. The sum of the (O- E)2/ E values for all the classification combinations= χ2. A 
significant χ2 indicates dependence between the variables.                   
 A second contingency chi-square was used to determine if prevalence of PI 
BVDV has dependence on season (Table 5). Since the calculated χ2 value of 0.8909 is 
less than the critical χ2 value of 7.815, the null hypothesis is accepted at the 0.05 level; 
frequency (prevalence) does not depend on category (season). 
 
Table 5. Contingency Chi-Square; Beef cattle testing positive for PI BVD by season. 
Season  Positive Negative Total 
Fall O 28 7391 7419 
 E 29.466 7389.534  
 (O-E)2/ E 0.0729 0.0003  
Winter O 15 4444 4459 
 E 17.710 4441.290  
 (O-E)2/ E 0.4147 0.0017  
Spring O 36 8153 8189 
 E 32.524 8156.476  
 (O-E)2/ E 0.3715 0.0015  
Summer O 18 4338 4356 
 E 17.301 4338.699  
 (O-E)2/ E 0.0282 0.001  
Total  97 24326 24423 
 
χ2 = ∑ (O-E)2/ E 
calculated χ2 = 0.8909 
df = 3 
critical χ2 (0.05, 3) = 7.815 
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Chapter Five 
Discussion 
 Results from this study may be used as additional support for PI testing as part of 
a BVDV control program. Data show an overall prevalence of 0.397% of sale barn 
animals as persistently infected with BVDV. Although prevalence does not depend on 
season, there is a higher prevalence of PI BVDV in lighter weight calves, especially those 
ranging in weight from 300 to 399 pounds (P<0.001). Although there is a seemingly low 
prevalence, these PI calves have a significant detrimental impact on other animals they 
come in contact with as a result of shedding abnormally high numbers of BVDV 
particles. Although the feedlot is an endpoint in terms of virus transmission, BVDV still 
has a great economic effect on this segment of the industry. Producers may feel that there 
is not an even trade-off between costs and benefits of testing, but data from this study 
show a uniform prevalence, and a testing and control program would be very beneficial. 
 Although the development of a government funded eradication program is not 
likely in the United States, the control of BVD is nevertheless important, and several 
control programs are currently in place. A major concern of any control program should 
include testing for and removal of any calves that are PI, and maintaining accurate 
records and documentation of testing. Once an animal has been tested PI negative, there 
is no need to retest it for PI. PI animals should be removed from the herd; they may be 
either humanely slaughtered, or grouped together in an isolated pen to prevent the spread 
of the virus, and then raised to market weight. A vaccination and testing program should 
also be developed that is specific for the type of operation, and vaccines should be given 
correctly. Producer failure appears to be more often at fault than vaccination failure. 
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Based on data from this study, PI testing and removal would be beneficial, and is 
especially justified in lighter weight sale barn calves. 
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